v3 Template
C
Crescendo Biologics
Biotechnology / Immuno-oncology
Founded
--
Employees
--
Total Funding
$32.0M
Funding Rounds
1
Last Funding
2023-07-24
About Crescendo Biologics
Crescendo Biologics is a T cell enhancing company focused on developing novel therapeutics in immuno-oncology.
Products & Services
Humabody® VH Platform:A proprietary platform for developing novel T cell enhancing therapeutics.
CB307:A lead clinical candidate in immuno-oncology, with clinical biodistribution data and trials for metastatic castration-resistant prostate cancer (mCRPC).
ZL-1102 (CB001):A topical treatment for psoriasis, currently in a global Phase 2 clinical trial.
CB699:A '2 in 1' immune cell engager, presented as a preclinical candidate at AACR 2024.
Specialties
T cell enhancing therapeutics
Immuno-oncology
Humabody® technology
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Venture Debt T: - FT: Venture Debt |
A: 32000000 MR: - FA: $32 million FAN: 32000000 |
D: 2023-07-24 FD: 2023-07-24 |
7 investors |
Venture Debt
Latest
2023-07-24
$32.0M
7 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Crescendo Biologics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- crescendobiologics.com
- Industries
- Biotechnology / Immuno-oncology
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro